Driehaus Capital Management LLC Neogenomics Inc Transaction History

Driehaus Capital Management LLC

$10.2 Billion
Q3 2024

A detailed history of Driehaus Capital Management LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Driehaus Capital Management LLC holds 387,643 shares of NEO stock, worth $6.52 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

387,643

Holding current value

$6.52 Million

% of portfolio

0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $5.19 Million - $6.87 Million	387,643 New	387,643 $5.72 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $3.95 Million - $7.02 Million	338,602 Added 76.41%	781,735 $12.6 Million
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $11,639 - $17,100	-958 Reduced 0.22%	443,133 $5.45 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $6.26 Million - $8.81 Million	444,091 New	444,091 $7.14 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $404,995 - $1.18 Million	-33,333 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $24.3 Million - $38.7 Million	-798,296 Reduced 95.99%	33,333 $1.14 Million
Q3 2021 Nov 15, 2021	BUY	$41.66 - $52.52 $11.2 Million - $14.1 Million	267,933 Added 47.53%	831,629 $40.1 Million
Q2 2021 Aug 16, 2021	SELL	$36.62 - $51.69 $3.61 Million - $5.09 Million	-98,498 Reduced 14.87%	563,696 $25.5 Million
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $5.21 Million - $7.51 Million	125,452 Added 23.37%	662,194 $31.9 Million
Q4 2020 Feb 16, 2021	SELL	$36.08 - $56.47 $1.67 Million - $2.62 Million	-46,315 Reduced 7.94%	536,742 $28.9 Million
Q3 2020 Nov 16, 2020	SELL	$33.26 - $40.48 $140,889 - $171,473	-4,236 Reduced 0.72%	583,057 $21.5 Million
Q2 2020 Aug 14, 2020	SELL	$24.21 - $31.02 $5.09 Million - $6.53 Million	-210,350 Reduced 26.37%	587,293 $18.2 Million
Q1 2020 May 15, 2020	BUY	$20.5 - $34.53 $2.11 Million - $3.55 Million	102,843 Added 14.8%	797,643 $22 Million
Q4 2019 Feb 12, 2020	BUY	$18.96 - $29.84 $4.64 Million - $7.31 Million	244,872 Added 54.42%	694,800 $20.3 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $8.84 Million - $12.1 Million	-462,410 Reduced 50.68%	449,928 $8.6 Million
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $3.19 Million - $3.93 Million	162,888 Added 21.73%	912,338 $20 Million
Q1 2019 May 15, 2019	SELL	$12.14 - $20.46 $83,486 - $140,703	-6,877 Reduced 0.91%	749,450 $15.3 Million
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $8.5 Million - $14 Million	756,327 New	756,327 $9.54 Million
Q4 2017 Feb 14, 2018	SELL	$8.02 - $11.18 $4.25 Million - $5.93 Million	-530,371 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$9.11 - $11.26 $4.83 Million - $5.97 Million	530,371	530,371 $5.9 Million

Others Institutions Holding NEO

# of Institutions

294

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.12B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Account

Driehaus Capital Management LLC Neogenomics Inc Transaction History